Arkapushpa Taila - Pharmaceutical review w.s.r. to Artavakshaya
Abstract
Women undergo rhythmic and periodic changes in the body that reflect and maintain fertility. These changes are externally visible as menstrual cycle. Menstruation is affected by a multitude of factors. There are issues related to menstruation that affect other systems and vice versa. It could also lead to sub fertility and infertility. Artavakshaya is one among those, where the menstruation is affected. Even though it is not mentioned separately as a disease but it appears as a symptom in many of the gynaecological disorders like oligomenorrhea / hypomenorrhea. In Ayurveda we have plenty of Dravyas and Yogas which help to treat the same. Even though we have plenty of options there are many formulations which are not yet explored, Arka (Calotropis procera) is one among them. We get reference of Arkapushpa Taila from Bharata Bhaishajya Ratnakara for Rudhirasrava. This basic concept is taken and an effort is made to understand the utility of this Taila in Artavakshaya. Even though the drug Arka is widely available, the unavailability of Arkapushpa Taila in the market made to prepare the Arkapushpa Taila and see the efficacy, difficulty and clinical utility of it.
Downloads
References
Nagindas and Gopinath G, Bharatha Bhaishajya Ratnavali. New Delhi: Jain Publication;2005.Vol 1.p.13.
Government of India, The Ayurvedic Pharmacopoeia of India, New Delhi: Cirrus Graphics Pvt.Ltd.;2008. Part 1, Vol 6.p224-25.
Jadavji Trikamji and Narayana Ram, Susrutha Samhita. New Delhi: Chaukhambha Publications; 2012.p70.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.